Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- TXN.NASDAQ
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
Texas Instruments Incorporated (TXN) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
PARTIAL SELL$258
-3.2%-1.2% incl. dividends5-Year
NEUTRAL$314
+17.7%+30.6% incl. dividendsPublished batch insight
Analog Giant Faces Structural Valuation Reset While Cash Flow Surges
Consensus reveals a sharp divergence between exceptional internal manufacturing execution and elevated valuation multiples. While 300-millimeter fab scale unleashes significant free cash flow post-capex crest, persistent five-percent discount rates and fixed depreciation schedules ensure valuation multiple compression largely absorbs operational earnings gains.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Superintelligence (Anthropologist), Michael Burry (Vulture), Warren Buffett (Value Purist), Universal Investor (Polymath), Elon Musk (Visionary), Machiavelli (Insider), Ray Dalio (Strategist), Sherlock Holmes (Whistleblower), J.P. Morgan (Titan). Some archetypes run in multiple modes, resulting in 14 advisors total.
Full published thesis
Executive Summary
If you invested $10,000 in Texas Instruments Incorporated at publication: $13,062 in five years versus $13,892 for S&P 500 benchmark.
* Return is calculated incl. 2.1% net dividend yield for Texas Instruments Incorporated.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter / date | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q118 Dec 2026 | 262.49 | -1.56% | -1.56% | Initial valuation friction dominates as benchmark Treasury yields compress technology multiples. Strong third-quarter shipments confirm operating recovery, but institutional profit-taking caps equity pricing near the anchor. |
| Q218 Mar 2027 | 258.47 | -1.53% | -3.06% | First-quarter order seasonal moderation and debt financing for the Silicon Labs acquisition absorb liquidity. Multiple compression slightly outweighs recovering earnings as channel replenishment stabilizes across industrial sectors. |
| Q318 Jun 2027 | 258.65 | +0.07% | -3.00% | Commercial production milestones at newly commissioned cleanrooms lower unpackaged die costs. Gross margins expand sequentially, enabling operational torque to counteract financing costs and establish solid valuation support. |
| Q418 Sept 2027 | 258.08 | -0.22% | -3.21% | Automotive and datacenter power management demand drives solid volume delivery. Expanding 300-millimeter utilization dilutes fixed depreciation overhead, sustaining earnings momentum despite persistent Chinese mature-node price competition. |
| Q518 Dec 2027 | 255.67 | -0.93% | -4.11% | Year-end capital expenditure disclosures ratify a step-down in cash outlays. Free cash flow inflection becomes undeniable, prompting institutional income accumulation while the board increases the annual dividend. |
| Q618 Mar 2028 | 257.59 | +0.75% | -3.40% | Improving unit manufacturing economics and initial Silicon Labs integration cross-selling support positive earnings revisions. The shares advance as market participants recognize expanding gross profit fall-through across catalog lines. |
| Q718 Jun 2028 | 260.31 | +1.06% | -2.37% | Broad-based factory automation and vehicle electrification demand lifts bookings. Operating leverage accelerates cash generation, driving quarterly performance above expectations as internal manufacturing exceeds eighty percent of total volume. |
| Q818 Sept 2028 | 261.11 | +0.31% | -2.07% | A temporary mid-cycle inventory pause across European industrial customers moderates sequential shipment velocity. Quoted prices consolidate quietly while management maintains catalog pricing discipline against localized competitive discounting. |
| Q918 Dec 2028 | 264.15 | +1.16% | -0.93% | Moderating capital commitments release substantial owner cash, allowing management to resume open-market share repurchases. Capital returns combined with resilient dividend yields attract defensive institutional capital into year-end. |
| Q1018 Mar 2029 | 269.66 | +2.09% | +1.13% | Insourcing acquired wireless products onto internal 300-millimeter wafer lines generates measurable manufacturing synergies. Net profit margins expand, allowing earnings compounding to outpace remaining valuation multiple drag. |
| Q1118 Jun 2029 | 277.10 | +2.76% | +3.92% | High-voltage power management for artificial intelligence infrastructure drives accelerating enterprise shipments. Operating cash flow conversion approaches historical peaks, reinforcing balance-sheet liquidity and supporting steady equity gains. |
| Q1218 Sept 2029 | 280.62 | +1.27% | +5.24% | Catalog component diversification across eighty thousand product nodes shields consolidated revenue from regional macroeconomic sluggishness. Steady booking linearity preserves high fab loading and consistent operating profitability. |
| Q1318 Dec 2029 | 284.24 | +1.29% | +6.60% | Substantial share count reductions amplify per-share earnings delivery. The market rewards dependable capital allocation discipline, with unencumbered free cash flow yields supporting consistent upward equity pricing. |
| Q1418 Mar 2030 | 288.64 | +1.55% | +8.25% | Edge artificial intelligence and autonomous robotics platforms enter commercial deployment, accelerating demand for precision analog interfaces. Texas Instruments' proprietary distribution reach captures high-margin multi-socket customer design wins. |
| Q1518 Jun 2030 | 294.96 | +2.19% | +10.62% | Redundant domestic 300-millimeter fabrication infrastructure achieves optimized cost efficiency. Cash conversion reaches multi-year highs, driving debt amortisation and funding uninterrupted quarterly share repurchases. |
| Q1618 Sept 2030 | 298.48 | +1.19% | +11.94% | Mature-node pricing competition from state-subsidized Asian foundries caps blended gross margin expansion. Quoted share prices pause in an orderly consolidation as secular volume growth balances pricing headwinds. |
| Q1718 Dec 2030 | 301.61 | +1.05% | +13.11% | Annual free cash flow expands past eight billion dollars, validating the decade-long manufacturing investment. Management executes expanded capital returns, delivering tangible per-share intrinsic value accretion to patient owners. |
| Q1818 Mar 2031 | 305.09 | +1.15% | +14.42% | Secular demand across industrial electrification and smart-grid infrastructure overcomes broader macroeconomic maturation. Steady catalog reorders drive dependable top-line expansion and sustained operational cash flow generation. |
| Q1918 Jun 2031 | 310.81 | +1.88% | +16.56% | High-margin analog catalog revenue compounds reliably, supported by internal packaging efficiencies and sticky customer design integrations. Operating margins approach historical bests, confirming the durable manufacturing economic moat. |
| Q2018 Sept 2031 | 313.92 | +1.00% | +17.73% | Five-year operational execution reaches steady-state equilibrium. Valuation multiples settle near normalized mid-cycle bands around twenty-four times earnings, concluding the post-capex valuation reset with durable shareholder gains. |
The investment thesis resolves a pivotal economic paradox: extraordinary operational torque colliding with severe valuation multiple compression. Internally, transition to proprietary 300-millimeter wafer manufacturing secures an unassailable forty percent unpackaged die cost advantage, while capital expenditure moderation from peak thirty percent levels liberates over eight billion dollars in normalized annual free cash flow. Furthermore, high incremental fall-through of seventy-five to eighty-five percent amplifies operating earnings as cyclical replenishment broadens into structural automotive and industrial electrification. However, equity pricing near forty times trailing earnings captures peak-cycle perfection in an era where five-percent risk-free Treasury yields aggressively penalize high-duration equities. Even acknowledging that forward guidance indicates a more palatable twenty-eight times forward earnings multiple, valuation gravity will inevitably pull terminal multiples toward historical medians of twenty-two to twenty-five times. Consequently, fundamental net income expansion will be substantially diluted by multiple de-rating, leaving equity appreciation muted while cash returns provide the bedrock of performance.
Key insights
- Operating leverage converts incremental volume directly into cash, but twenty-eight times forward earnings already discounts substantial operational execution.
- Sunk fab depreciation exceeding two billion dollars annually and pending acquisition debt restrict aggressive near-term share buybacks.
- Domestic 300-millimeter manufacturing scale insulates Western supply chains, yet commoditized Chinese analog substitution caps long-term catalog pricing power.
Texas Instruments is a dominant semiconductor manufacturer completing a massive multi-year factory upgrade. Moving production to large 300-millimeter silicon wafers cuts manufacturing costs by forty percent, while annual construction bills are finally dropping. This combination is turning the business back into an immense cash-generating machine. However, the stock price already reflects immense optimism, trading at an expensive forty times past earnings while safe government bonds pay five percent. As market expectations return to historical norms, shrinking valuation multiples will absorb much of the company's profit growth, delivering modest share price gains centered on reliable dividend payouts.
Key insights
- Factory construction spending is declining sharply, allowing cash flow to surge back toward historic records.
- High stock valuation multiples will likely shrink over time, offsetting a large portion of earnings growth.
- Growing automotive and factory automation demand ensures dependable long-term sales despite low-end Chinese competition.
Deep Dive
The prevailing market belief treats Texas Instruments as an untouchable analog tollbooth enjoying a seamless cyclical turnaround. Investors assume that surging quarterly revenues, expanding artificial intelligence datacenter power shipments, and completed fab construction justify an elevated forty times trailing earnings multiple, presupposing that capital expenditure tapering will effortlessly deliver twelve dollars per share in unencumbered free cash flow.